Melissa Simpson leads the Oceania Clinical Development Centre at Novo Nordisk, overseeing clinical trial strategy and execution across Australia and New Zealand. With close to 20 years in the research, pharmaceutical and CRO sectors; she brings deep expertise in trial design execu-tion, regulatory strategy, and cross-functional leadership.
Melissa has experience executing clinical trials with a focus on project management, start up and operational teams across all phases, including health volunteer trials. This experience spans mul-tiple regions (APAC, Europe, and US), and across several therapeutic areas including, Oncology, Neurovascular, Immunology, endocrine, infectious diseases and cardiometabolic diseases.
Melissa is a passionate advocate for equitable access to clinical research and has championed initiatives to improve trial diversity and decentralised trial models.